Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study.
Gaudet D, López-Sendón JL, Averna M, Bigot G, Banach M, Letierce A, Loy M, Samuel R, Manvelian G, Batsu I, Henry P; ODYSSEY APPRISE Study investigators.
Gaudet D, et al. Among authors: samuel r.
Eur J Prev Cardiol. 2022 Feb 3;28(17):1864-1872. doi: 10.1093/eurjpc/zwaa097.
Eur J Prev Cardiol. 2022.
PMID: 33624041
Clinical Trial.